Literature DB >> 19447215

Desirable effect of combination therapy with high molecular weight hyaluronate and NSAIDs on MMP production.

M Hashizume1, M Mihara.   

Abstract

OBJECTIVE: We previously reported that nonsteroidal anti-inflammatory drugs (NSAIDs) aggravated cartilage degeneration and that hyaluronate (HA) reversed the cartilage destruction accelerated by NSAIDs in a rabbit osteoarthritis (OA) model. In the present study, we analyzed the mechanisms of these effects of NSAIDs and HA.
METHOD: An experimental rabbit model of OA was induced by partial meniscectomy and treated with NSAIDs, HA and the combination of NSAIDs and HA over 2 weeks. After sacrifice, cartilage degeneration and the levels of matrix metalloproteases (MMP)-1, MMP-3 and MMP-13 in synovial lavage fluid were measured. In an in vitro study, human articular chondrocytes were cultured with NSAIDs and HA in the presence of interleukin (IL)-1beta or IL-6+sIL-6 for 24 h. After culture, the production of MMPs, IL-1beta, and IL-6 was measured.
RESULTS: The levels of MMP-1, MMP-3 and MMP-13 in synovial fluid from the NSAID-treated group were significantly higher than in controls. The increased production of MMPs induced by NSAIDs was counteracted by the concomitant administration of HA. In vitro studies showed that NSAIDs augmented IL-1beta- and IL-6-induced production of MMPs from human chondrocytes, while completely inhibiting the IL-1beta- and IL-6/sIL-6R-induced production of prostaglandin E(2) (PGE(2)). The addition of PGE(2) did not reduce the augmentation of MMP production. HA inhibited the promotion of cytokine-induced MMP and cytokine production by NSAIDs.
CONCLUSIONS: Our data clearly showed that HA inhibited NSAID-accelerated MMP production which was followed by inflammatory cytokine production from cytokine-activated chondrocytes. The results warrant further evaluation of the potential chondroprotective effects of co-administration of HA with NSAIDs.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19447215     DOI: 10.1016/j.joca.2009.04.018

Source DB:  PubMed          Journal:  Osteoarthritis Cartilage        ISSN: 1063-4584            Impact factor:   6.576


  18 in total

Review 1.  Hyaluronan in the experimental injury of the cartilage: biochemical action and protective effects.

Authors:  Angela Avenoso; Angela D'Ascola; Michele Scuruchi; Giuseppe Mandraffino; Alberto Calatroni; Antonino Saitta; Salvatore Campo; Giuseppe M Campo
Journal:  Inflamm Res       Date:  2017-08-12       Impact factor: 4.575

2.  Anti-Inflammatory Effects of Intra-Articular Hyaluronic Acid: A Systematic Review.

Authors:  Roy Altman; Asheesh Bedi; Ajay Manjoo; Faizan Niazi; Peter Shaw; Philip Mease
Journal:  Cartilage       Date:  2018-02-11       Impact factor: 4.634

3.  Harpagoside suppresses IL-6 expression in primary human osteoarthritis chondrocytes.

Authors:  Abdul Haseeb; Mohammad Yunus Ansari; Tariq M Haqqi
Journal:  J Orthop Res       Date:  2016-05-04       Impact factor: 3.494

4.  Hyaluronan suppresses mechanical stress-induced expression of catabolic enzymes by human chondrocytes via inhibition of IL-1β production and subsequent NF-κB activation.

Authors:  Masatsugu Ozawa; Keiichiro Nishida; Aki Yoshida; Taichi Saito; Ryozo Harada; Takahiro Machida; Toshifumi Ozaki
Journal:  Inflamm Res       Date:  2015-02-19       Impact factor: 4.575

5.  Effects of low molecular weight hyaluronan combined with carprofen on canine osteoarthritis articular chondrocytes and cartilage explants in vitro.

Authors:  Thippaporn Euppayo; Puntita Siengdee; Kittisak Buddhachat; Waranee Pradit; Nawarat Viriyakhasem; Siriwadee Chomdej; Siriwan Ongchai; Yasuji Harada; Korakot Nganvongpanit
Journal:  In Vitro Cell Dev Biol Anim       Date:  2015-05-16       Impact factor: 2.416

6.  MicroRNA-9 promotion of interleukin-6 expression by inhibiting monocyte chemoattractant protein-induced protein 1 expression in interleukin-1β-stimulated human chondrocytes.

Authors:  Mohammad S Makki; Abdul Haseeb; Tariq M Haqqi
Journal:  Arthritis Rheumatol       Date:  2015-05       Impact factor: 10.995

7.  The roles of interleukin-6 in the pathogenesis of rheumatoid arthritis.

Authors:  Misato Hashizume; Masahiko Mihara
Journal:  Arthritis       Date:  2011-05-26

8.  Interleukin-6 is elevated in synovial fluid of patients with focal cartilage defects and stimulates cartilage matrix production in an in vitro regeneration model.

Authors:  Anika I Tsuchida; Michiel Beekhuizen; Marijn Rutgers; Gerjo J V M van Osch; Joris E J Bekkers; Arjan G J Bot; Bernd Geurts; Wouter J A Dhert; Daniel B F Saris; Laura B Creemers
Journal:  Arthritis Res Ther       Date:  2012-12-03       Impact factor: 5.156

9.  Comparison of piroxicam pharmacokinetics and anti-inflammatory effect in rats after intra-articular and intramuscular administration.

Authors:  Chan Woong Park; Kyung Wan Ma; Sun Woo Jang; Miwon Son; Myung Joo Kang
Journal:  Biomol Ther (Seoul)       Date:  2014-05       Impact factor: 4.634

10.  miR-139 modulates MCPIP1/IL-6 expression and induces apoptosis in human OA chondrocytes.

Authors:  Mohammad Shahidul Makki; Tariq M Haqqi
Journal:  Exp Mol Med       Date:  2015-10-09       Impact factor: 8.718

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.